Topical Prostaglandin-E1 for the Treatment of Erectile Dysfunction
- 1 June 1995
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 153 (6) , 1828-1830
- https://doi.org/10.1016/s0022-5347(01)67323-3
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Papaverine Topical Gel for Treatment of Erectile DysfunctionJournal of Urology, 1995
- Prospective comparison of topical minoxidil to vacuum constriction device and intracorporeal papaverine injection in treatment of erectile dysfunction due to spinal cord injuryUrology, 1994
- Intraurethral prostaglandin E-2 cream: A possible alternative treatment for erectile dysfunctionUrology, 1993
- The relationship between time of application of Prostaglandin E1 and improved flap survivalBritish Journal of Plastic Surgery, 1993
- Improved transdermal delivery of prostaglandin E1 through hairless mouse skin: combined use of carboxymethyl-ethyl-β-cyclodextrin and penetration enhancersJournal of Pharmacy and Pharmacology, 1992
- The role of intracavernous injection of vasoactive medications for the restoration of erection in spinal cord injured males: a three year follow upSpinal Cord, 1992
- Aspects of the transdermal delivery of prostaglandinsInternational Journal of Pharmaceutics, 1991
- Topical Nitroglycerin: A Potential Treatment for ImpotenceJournal of Urology, 1989
- Side effects of therapy with prostaglandin E1 in infants with critical congenital heart disease.Circulation, 1981
- Regional Variation in Percutaneous Penetration in ManArchives of environmental health, 1971